A USD 4.2 Billion Myovant/ Pfizer Deal; Audentes Therapeutics’ ASPIRO Trial Free to Proceed; First Generic of Drug for Severe Hypoglycemia Gets Approval; Teleflex Acquires Z-Medica
Delveinsight
DECEMBER 29, 2020
X-linked myotubular myopathy (XLMTM) is a rare genetic neuromuscular disorder and leads to muscle weakness, respiratory failure, and early death. It is a complication associated with diabetic patients who take insulin and certain anti-diabetic tablets. Approximately 1 in 40,000 to 50,000 newborn males are diagnosed with the disease.
52 
Let's personalize your content